Abstract
The United States' population is aging. Epidemiological surveys suggest significant rates of mental illness amongst the rapidly growing over-65 cohort. A burgeoning experience and data base related to the developing sub-discipline of geriatric psychiatry is now available. This article synthesizes key issues and concepts as an introduction to geropsychiatric practice—in particular, a) the interface between medical illness and psychiatric expression in the elderly, b) delirium, c) dementia, and d) depression—and considers their interactions. Finally, there is a brief overview of geriatric psychopharmacology, followed by clinically-oriented discussions of each of the major classes of psychotropics as applied to a geriatric population.
Similar content being viewed by others
References
U.S. Department of Commerce, Bureau of Census, Decennial Censuses of Population, 1900–1980 and Projections of the Population of the United States: 1982–2050 (Advance Report). Current Population Reports, Series P-25, No. 922, 1982.
Rubenstein LZ, Josephson KR, Wieland GD, English PA, Sayre JA, Kane RL. Effectiveness of a geriatric evaluation unit: a randomized clinical trial. New Engl J Med 311: 1664–70, 1984.
Rowe JW. Health care of the elderly. New Engl J Med 312: 827–835, 1985.
Myers JK, Weissman MM, Tischler GL, Holzer CE III, Leaf PH, Orvaschel H, Anthony JC, Boyd JH, Burke JD Jr., Kramer M, Stoltzman R. Six-month prevalence of psychiatric disorders in three communities: 1980–1982. Arch Gen Psychiatry 41: 959–967, 1984.
Rovner BW, Kafonek S, Filipp L, Lucas MJ, Folstein MF. Prevalence of mental illness in a community nursing home. Am J Psychiatry 143: 1446–1449, 1986.
Chandler JD, Chandler JE. The prevalence of neuropsychiatric disorders in a nursing home population. J Geriatr Psychiatry Neurol 1: 71–76, 1988.
Burns BJ, Larson DB, Goldstrom ID, Johnson WE, Taube CA, Miller NE, Mathis ES. Mental disorder among nursing home patients: preliminary findings from the national nursing home survey pretest. Int J Geriatr Psychiatry 3:27–35, 1988.
Moak GS, Fisher WH. Geriatric patients and services in state hospitals: data from a national survey. Hosp Comm Psychiatry 42: 273–276, 1991.
Kane DL, Solomon DH, Beck DC, Keeler EB, Kane RA.Geriatrics in the United States. Manpower Projections and Training Considerations. Lexington Books, Lexington, Mass., 1981.
Thompson TL, Moran MG, Nies AS. Psychotropic drug use in the elderly. New Engl J Med 308:134–138; 194–199, 1983.
Lipowski ZJ. Transient cognitive disorders (delirium, acute confusional states) in the elderly. Am J Psychiatry 140: 1426–1436, 1983.
American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders (third edition—revised) American Psychiatric Association, Washington, D.C., 1987.
Lipowski ZJ. Delirium in the elderly patient. New Engl J Med 320: 578–582, 1989.
Beresin EV.Delirium in the elderly: assessment and management. A monograph (Clinical perspectives on aging) Wyeth Laboratories, Philadelphia, PA, 1985.
Sunderland T, Tariot PN, Cohen RM, Weingartner H, Mueller EA, Murphy DL. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and agematched controls. A dose-response study. Arch Gen Psychiatry 44: 418–426, 1987.
Lipsitz LA. Orthostatic hypotension in the elderly. New Engl J Med 321: 952–956, 1989.
Wrenn K. Fecal impaction. New Engl J Med 321: 658–662, 1989.
Resnick NM, Yalla SV. Management of urinary incontinence in the elderly. New Engl J Med 313: 800–805, 1985.
Tinetti ME, Speechley M. Prevention of falls among the elderly. New Engl J Med 320: 1055–1059, 1988.
Prince RL, Smith M, Dick IM, Price RI, Webb PG, Henderson NK, Harris MM. Prevention of postmenopausal osteoporosis. New Engl J Med 325: 1189–1195, 1991.
Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 262: 2551–2556, 1989.
Moak GS, Fisher WH. Alzheimer's disease and related disorders in state mental hospitals: data from a nationwide survey. Gerontologist 30:798–802, 1990.
Lieberman A, Dziatolowski M, Kupersmith M, Serby M, Goodgold A, Korein J, Goldstein M. Dementia in Parkinson disease. Ann Neurol 6: 355–359, 1979.
Cummings JL. Multi-infarct dementia: diagnosis and management. Psychosomatics 28:117–126, 1987.
Nott PN, Fleminger JJ. Presenile dementia: the difficulties of early diagnosis. Acta Psychiat Scand 51: 210–217, 1975.
Freemon FR. Evaluation of patients with progressive intellectual deterioration. Arch Neurol 33: 658–659, 1976.
Ron MA, Toone BK, Garralda ME, Lishman WA. Diagnostic accuracy in presenile dementia. Brit J Psychiat 134: 161–168, 1979.
Marsden CD, Harrison MJG. Outcome of investigation of patients with presenile dementia. Brit Med Journal 2: 249–252, 1972.
Smith JS, Kiloh LG, Ratnavale GS, Grant DA. The investigation of dementia. The results in 100 consecutive admissions. Med J Aust 2: 403–405, 1976.
Larson EB, Reifler BV, Featherstone HJ, English DR. Dementia in elderly outpatients: a prospective study. Annal of Internal Medicine 100: 417–423, 1984.
Reding M, Haycox J, Blass J. Depression in patients referred to a dementia clinic. A three year prospective study. Arch Neurol 42: 894–896, 1985.
Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment. J Clin Psychiatry 48[5, suppl]: 9–15, 1987.
Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J of Gerontology 44: M77–84, 1989.
Swearer JM, Drachman DA, O'Donnell BF, Mitchell AL. Troublesome and disruptive behaviors in dementia. Relationships to diagnosis and disease severity. J Am Geriatr Soc 36:784–790, 1988.
Cohen-Mansfield J, Billig N. Agitated behaviors in the elderly. I. A conceptual review. J Am Geriatr Soc 34:711–721, 1986.
Salzman C, Shader RI. Clinical evaluation of depression in the elderly. In:Psychiatric Symptoms and Cognitive Loss in the Elderly, edited by Raskin A, Jarvik LF. Hemisphere Publishing Co., Washington, D.C., 1979.
Rodin J. Aging and health: effects of the sense of control. Science 233: 1271–1276, 1986.
Seligman M, Maier S. Failure to escape traumatic shock. J of Experimental Psychology 74: 1–9, 1967.
Blazer D. The diagnosis of depression in the elderly. J Am Geriatr Soc 28: 52–58, 1980.
Meyers BS, Greenberg R. Late-life delusional depression. J Affective Disorders 11: 133–137, 1986.
Brown RP, Sweeney J, Loutsch E, Kocsis J, Frances A. Involutional melancholia revisited. Am J Psychiatry 141: 24–28, 1984.
Salzman C, Shader RI. Depression in the elderly. I. Relationship between depression, psychologic defense mechanisms and physical illness. J Am Geriatr Soc 26: 253–260, 1978.
Folstein MF, McHugh PR. Dementia syndrome of depression. In:Alzheimer's Disease: Senile Dementia and Related Disorders (Aging Vol. 7), edited by R Katzman, RD Terry, KL Bick. Raven Press, New York, 1978.
Reifler BV. Arguments for abandoning the term pseudodementia. J Am Geriatr Soc 30:665–668, 1982.
Reifler BV. Mixed cognitive-affective disturbances in the elderly: a new classification. J Clin Psychiatry 47:354–356, 1986.
McAllister TW. Overview: pseudodementia. Am J Psychiatry 140: 528–533, 1983.
Post F. Somatic and psychic factors in the treatment of elderly psychiatric patients. J Psychosomatic Res 10: 13–19, 1966.
LaRue A, Spar J, Hill CD. Cognitive impairment in late-life depression: clinical correlates and treatment implications. J Affective Disorders 11: 179–184, 1986.
Greenwald BS, Kramer E, Wachter E, Losonczy MF, Aisen P. Late life depressive pseudodementia. APA New Research Abstracts, APA, Washington, D.C., 1989.
Roth M. Senile dementia and its borderlands. In:Psychopathology in the Aged, edited by JO Cole, JE Barrett. Raven Press, New York, 1980.
Rabins PV, Merchant A, Nestadt G. Criteria for diagnosing reversible dementia caused by depression: validation by 2-year follow-up. Brit J Psychiatry 144: 488–492, 1984.
Caine ED. Pseudodementia. Current concepts and future directions. Arch Gen Psychiatry 38:1359–1364, 1981.
Benson DF. Subcortical dementia: a clinical approach. In:The Dementias, edited by R. Mayeux, WG Rosen. Raven Press, New York, 1983.
Pearlson GD, Rabins PV, Kim WS, Speedie LJ, Moberg PJ, Burns A, Bascom MJ. Psychological Medicine 19: 573–584, 1989.
Kramer E, Greenwald BS. Old age depressive pseudodementia: 3–4 year follow-up. APA New Research Abstracts, APA, Washington, D.C., 1990.
Kral VA. The relationship between senile dementia (Alzheimer type) and depression. Can J Psychiatry 28: 304–306, 1983.
Kral VA, Emery OB. Long term follow-up of depressive pseudodementia of the aged. Can J Psychiatry 38:445–446, 1989.
Greenwald BS, Kramer-Ginsberg E, Marin DB, Laitman LB, Hermann CK, Mohs RC, Davis KL. Dementia with coexistent major depression. Am J Psychiatry 146: 1472–1478, 1989.
Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 146:577–587, 1989.
Merriam AE, Aronson MK, Gaston P, Wey SL, Katz I. The psychiatric symptoms of Alzheimer's disease. J Am Geriatr Soc 36: 7–12, 1988.
Mackenzie RB, Robiner WN, Knopman DS. Differences between patient and family assessments of depression in Alzheimer's disease. Am J Psychiatry 146:1174–1178, 1989.
Lazarus LW, Newton N, Cohler B, Lesser J, Schweon C. Frequency and presentation of depressive symptoms in patients with primary degenerative dementia. Am J Psychiatry 144: 41–45, 1987.
Pomara N, Stanley B, Block R, Berchou RC, Stanley M, Greenblatt DJ, Newton RE, Gershon S. Increased sensitivity of the elderly to the central depressant effects of diazepam. J Clin Psychiatry 46: 185–187, 1985.
Salzman C, Shader RI, Greenblatt DJ, Harmatz JS. Long v short half-life benzodiazepines in the elderly. Kinetics and clinical effects of diazepam and oxazepam. Arch Gen Psychiatry 40: 293–297, 1983.
Jarvik LF, Gerson S. Outcome of drug treatment in depressed patients over the age of fifty. In:Treatment of Affective Disorders in the Elderly. Edited by CA Shamoian. APA Press, Washington, DC, 1985.
Salzman C.Clinical Geriatric Psychopharmacology McGraw Hill Book Co., New York, 1984.
Robinson DS. Changes in monoamine oxidase and monoamines with human development and aging. Fed Proc 34: 103–107, 1975.
Ashford JW, Ford CV. Use of MAO inhibitors in elderly patients. Am J Psychiatry 136: 1466–1467, 1979.
Jenike MA. The use of monoamine oxidase inhibitors in the treatment of elderly, depressed patients. J Am Geriatr Soc 32: 571–575, 1984.
Lazarus LW, Groves L, Gierl B, Pandey G, Javaid JI, Lesser J, Ha YS, Davis J. Efficacy of phenelzine in geriatric depression. Biol Psychiatry 21: 699–701, 1986.
Georgotas A, Friedman E, McCarthy M, Mann J, Krakowski M, Siegel R, Ferris S. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors. Biological Psychiatry 18: 195–205, 1983.
Georgotas A, McCue RE, Hapworth W, Friedman E, Kim OM, Welkowitz J, Chang I, Cooper TB. Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly. Biol Psychiatry 21: 1155–1166, 1986.
Georgotas A, McCue RE, Cooper TB. The placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 46: 783–786, 1989.
Gerner R, Estabrook W, Steuer J, Jarvik L. Treatment of geriatric depression with trazodone, imipramine, and placebo: a double-blind study. J Clin Psychiatry 41: 216–219, 1980.
Rauch PK, Jenike MA. Digoxin toxicity possibly precipitated by trazodone. Psychosomatics 25: 334–335, 1984.
Feighner JP, Cohn JB. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry 46 [3, sec.2]: 20–25, 1985.
Feighner FP, Boyer WF, Meredith CH, Hendrickson G. An overview of fluoxetine in geriatric depression. Brit J Psychiatry 153: [suppl 3] 105–108, 1988.
Branconnier RJ, Cole JO, Ghazvinian S, Spera KF, Oxenkrug GF, Bass JL. Clinical pharmacology of bupropion and imipramine in elderly depressives. J Clin Psychiatry 44: [sec. 2] 130–133, 1983.
Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EGV. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 148: 512–516, 1991.
Barnes R, Veith R, Okimoto J, Raskind M, Gumbrecht G. Efficacy of antipsychotic medications in behaviorally disturbed dementia patients. Am J Psychiatry 139: 1170–1174, 1982.
Saltz BL, Kane JM, Woerner MG, Lieberman JA, Alvir JMA, Blank K, Kahaner K, Foley C. Prospective study of tardive dyskinesia in the elderly. Psychopharm Bull 25: 52–56, 1989.
Finch EJL, Katona CLE. Lithium augmentation in the treatment of refractory depression in old age. Intl J Geriatr Psychiatry 4: 41–46, 1989.
Kushnir SL. Lithium-antidepressant combinations in the treatment of depressed, physically ill geriatric patients. Am J Psychiatry 148: 378–379, 1986.
Hardy BG, Shulman KI, Mackenzie SE, Kutcher SP, Silverberg JD. Pharmacokinetics of lithium in the elderly. J Clin Psychopharm 7: 153–158, 1987.
Foster JR, Silver M, Boksay IJE. Lithium in the elderly: A review with special focus on the use of intraerythrocyte (RBC) levels in detecting serious impending neurotoxicity. Intl J Geriatr Psychiatry 5: 1–7, 1990.
Burke WJ, Rubin EH, Zorumski CF, Wetzel RD. The safety of ECT in geriatric psychiatry. J Am Geriatr Soc 35: 516–521, 1987.
Benbow SM. The role of electroconvulsive therapy in the treatment of depressive illness in old age. Brit J Psychiatry 155: 147–152, 1989.
Horne RL, Pettinati HM, Sugerman AA, Varga E. Comparing bilateral to unilateral electroconvulsive therapy in a randomized study with EEG monitoring. Arch Gen Psychiatry 42: 1087–1092, 1985.
Sackeim HA, Decina P, Kanzler M, Kerr B, Malitz S. Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry 144: 1449–1455, 1987.
Spiker DG, Weiss JC, Dealy RS, Griffin SJ, Hanin I, Neil JF, Perel JM, Rossi AJ, Soloff PH. The pharmacological treatment of delusional depression. Am J Psychiatry 142: 430–436, 1985.
Meyers BS, Greenberg R, Mei-Tal V. Delusional depression in the elderly. In:Treatment of Affective Disorders in the Elderly. Edited by CA Shamoian, APA Press, Washington D.C., 1985.
Reifler BV, Teri L, Raskind M, Veith R, Barnes R, White E, McLean P. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. Am J Psychiatry 146: 45–49, 1989.
Price TRP, McAllister TW. Safety and efficacy of ECT in depressed patients with dementia: a review of clinical experience. Convulsive Therapy 5: 61–74, 1989.
Coffey CE, Figiel GS, Djang WT, Sullivan DC, Herfkens RJ, Weiner RD. Effects of ECT on brain structure: a pilot prospective magnetic resonance imaging study. Am J Psychiatry 145: 701–706, 1988.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Greenwald, B.S., Kremen, N. & Aupperle, P. Tailoring adult psychiatric practices to the field of geriatrics. Psych Quart 63, 343–366 (1992). https://doi.org/10.1007/BF01066763
Issue Date:
DOI: https://doi.org/10.1007/BF01066763